NET PROFIT (x1000 EUR)
EMPLOYEES
Biosyntia ApS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-3,272
|
-4,504
|
-4,478 |
| Total assets |
9,272
|
12,406
|
16,407 |
| Current assets |
9,098
|
12,199
|
16,254 |
| Current liabilities |
1,170
|
859
|
581 |
| Equity capital |
7,095
|
9,639
|
13,618 |
| - share capital |
108
|
108
|
108 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.5%
|
77.7%
|
83.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
777.6%
|
1420.1%
|
2797.6% |
| Return on equity (ROE) |
-46.1%
|
-46.7%
|
-32.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.